Product Image

Contributor Information

  • Name D.L. Hardie
  • Institute University of Birmingham

Tool Details

  • Tool name: Anti-CD55 [BU14]
  • Alternate names: CD55 Molecule (Cromer Blood Group); CD55 Molecule; Decay Accelerating Factor For Complement (Cromer Blood Group); CD55 Antigen; DAF; CR; Decay Accelerating Factor For Complement; CROM; TC
  • Clone: BU14
  • Tool type: Antibodies
  • Tool sub-type: Primary antibody
  • Class: Monoclonal
  • Conjugate: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: FACS ; IP
  • Strain: Balb/c
  • Description: CD97 is a member of the epidermal growth factor-seven transmembrane family. It affects tumour aggressiveness by binding its cellular ligand CD55 and exhibits adhesive properties. Previous studies have shown that CD97 and CD55 are involved in the dedifferentiation, migration, invasiveness and metastasis of tumours.
  • Isotype: IgG1
  • Research area: Adhesion; Cancer; Cell Type or Organelle Marker; Immunology

  • For Research Use Only

Target Details

  • Target: CD55 (CD97 ligand)
  • Target background: CD97 is a member of the epidermal growth factor-seven transmembrane family. It affects tumour aggressiveness by binding its cellular ligand CD55 and exhibits adhesive properties. Previous studies have shown that CD97 and CD55 are involved in the dedifferentiation, migration, invasiveness and metastasis of tumours.

Application Details

  • Application: FACS ; IP

Handling

  • Format: Liquid
  • Shipping conditions: Shipping at 4°C

Documentation

  • Available on request

References

  •   Ling et al. 1998. Clin Exp Immunol. 113(3):360-6. PMID: 9737663.
  •   Origin and properties of soluble CD21 (CR2) in human blood.